rs147255018

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001018113.3(FANCB):​c.2090C>T​(p.Pro697Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000585 in 1,207,387 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 218 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P697P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., 12 hem., cov: 22)
Exomes 𝑓: 0.00061 ( 0 hom. 206 hem. )

Consequence

FANCB
NM_001018113.3 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.865

Publications

2 publications found
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
FANCB Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • VACTERL association, X-linked, with or without hydrocephalus
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • VACTERL with hydrocephalus
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02082172).
BP6
Variant X-14844578-G-A is Benign according to our data. Variant chrX-14844578-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 246613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 12 AR,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCBNM_001018113.3 linkc.2090C>T p.Pro697Leu missense_variant Exon 9 of 10 ENST00000650831.1 NP_001018123.1 Q8NB91A0A024RBW1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkc.2090C>T p.Pro697Leu missense_variant Exon 9 of 10 NM_001018113.3 ENSP00000498215.1 Q8NB91

Frequencies

GnomAD3 genomes
AF:
0.000359
AC:
40
AN:
111327
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000980
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000698
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000240
AC:
44
AN:
183255
AF XY:
0.000251
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000514
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000608
AC:
666
AN:
1096005
Hom.:
0
Cov.:
30
AF XY:
0.000570
AC XY:
206
AN XY:
361465
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26355
American (AMR)
AF:
0.00
AC:
0
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19366
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30187
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54086
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4131
European-Non Finnish (NFE)
AF:
0.000775
AC:
651
AN:
840144
Other (OTH)
AF:
0.000283
AC:
13
AN:
46004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000359
AC:
40
AN:
111382
Hom.:
0
Cov.:
22
AF XY:
0.000357
AC XY:
12
AN XY:
33646
show subpopulations
African (AFR)
AF:
0.0000978
AC:
3
AN:
30678
American (AMR)
AF:
0.00
AC:
0
AN:
10526
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3543
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2687
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5913
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000698
AC:
37
AN:
52982
Other (OTH)
AF:
0.00
AC:
0
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000547
Hom.:
22
Bravo
AF:
0.000363
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00138
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.000247
AC:
30
EpiCase
AF:
0.000600
EpiControl
AF:
0.000474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia Benign:2
Feb 07, 2021
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 19, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FANCB-related disorder Benign:1
Nov 20, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FANCB: BP4, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
4.6
DANN
Benign
0.24
DEOGEN2
Benign
0.37
T;T;T
FATHMM_MKL
Benign
0.060
N
LIST_S2
Benign
0.81
T;.;T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.021
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.8
L;L;.
PhyloP100
0.86
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-4.2
D;D;D
REVEL
Benign
0.054
Sift
Benign
1.0
T;T;T
Sift4G
Benign
0.73
T;T;T
Polyphen
0.054
B;B;.
Vest4
0.18
MVP
0.11
MPC
0.11
ClinPred
0.034
T
GERP RS
1.5
Varity_R
0.062
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147255018; hg19: chrX-14862700; COSMIC: COSV105907109; API